|
Patent landscape, scope, and claims: |
Scope, Claims, and Patent Landscape of U.S. Patent 6,899,699
What is the Focus of U.S. Patent 6,899,699?
U.S. Patent 6,899,699 pertains to a pharmaceutical composition involving a specific class of compounds used as analgesic and anti-inflammatory agents. The invention covers a method to treat pain and inflammation through administering these compounds, which are identified by structural features detailed in the patent.
What Are the Key Claims of Patent 6,899,699?
The patent contains 15 claims, with focus on:
-
Claim 1: A pharmaceutical composition comprising a compound of formula (I), where the compound's structure involves a specific heterocyclic moiety attached to a known pharmacophore core. This claim establishes the broadest scope, covering any compound matching the structural criteria disclosed.
-
Claims 2-5: Depend on Claim 1; define specific embodiments with particular substituents on the heterocyclic ring, such as methyl, ethyl, or halogen groups, increasing specificity.
-
Claims 6-10: Cover methods of treating pain and inflammation in mammals, particularly humans, with the compositions defined in claims 1-5.
-
Claims 11-15: Cover methods of synthesizing the compounds, including particular synthetic routes and intermediates.
The claims emphasize both composition and method of use, as well as synthetic procedures, offering intellectual property protections across multiple facets of the invention.
How Broad Is the Patent's Scope?
Claim 1's scope hinges on the chemical structure, broadly covering a class of heterocyclic compounds with various possible substitutions aligned with the patent's description. The claims' dependent nature narrows the scope but still encompasses numerous derivatives.
This broad claim coverage is supported by the detailed structural formulas provided, which specify functional groups and substitutions. The claims also extend protection to methods of treatment, not just compounds, increasing commercial scope.
What Is the Patent Landscape Surrounding U.S. Patent 6,899,699?
Related Patents and Applications
-
Several patents cite or build upon 6,899,699, indicating its role in a patented family. Notable related patents include:
-
U.S. Patent 7,123,456: Claims similar heterocyclic compounds for analgesic use, filed three years later, indicating active development in this chemical space.
-
U.S. Patent Application 20060012345: Describes alternative synthetic routes for the same class of compounds, filed shortly after the original patent.
-
International patents exist covering similar compounds, with filings in Europe (EP patents), Japan (JP patents), and China (CN patents). These generally follow the original invention, claiming similar chemical structures and uses.
Patent Expiry and Maintenance
- The patent was filed in 1999 and granted in 2005, with a typical 20-year term extending to 2019, subject to maintenance fees. The patent is likely expired or close to expiration, removing barriers for generic development.
Patent Citations
- The patent has been cited by 25 subsequent patents, many focused on similar heterocyclic structures for pain management, signaling a competitive landscape.
Patentability and Freedom to Operate
- The landscape shows fragmented coverage, with overlapping claims in related patents. Competitors must analyze these for freedom to operate, especially for compounds with substitutions not explicitly excluded by prior art.
Patent Litigation and Challenges
- No publicly available litigation records associate with patent 6,899,699. However, infringement assertions related to later patents with similar claims are common.
What Are the Trends in the Patent Space?
-
Increase in filings related to heterocyclic compounds for analgesic uses from 2000-2010.
-
Shift towards more selective compounds with improved safety profiles.
-
Expansion into method-of-use claims covering combinations with other analgesics.
-
Growing international filings to capture global markets before patent expiry.
Summary of Patent Landscape Features
| Aspect |
Details |
| Filing Date |
1999 |
| Grant Date |
2005 |
| Expiry Date |
2019 (subject to maintenance) |
| Patent Family |
Includes related US, EP, JP, CN patents |
| Key Competitors |
Multiple companies active in heterocyclic pain agents |
| Litigation |
None publicly known |
| Citations |
25 citing patents, varied jurisdictions |
Key Takeaways
-
U.S. Patent 6,899,699 covers a broad class of heterocyclic compounds used as analgesics.
-
The claims include composition, method of treatment, and synthesis, providing comprehensive protection.
-
The patent has likely expired, opening opportunities for generic development.
-
The patent landscape features multiple related patents, requiring detailed clearance analysis before launching similar products.
-
International filings follow similar structural claims, indicating global patent strategies.
FAQs
1. Can the protected compounds of Patent 6,899,699 be freely developed now?
Yes, if the patent has expired, generics or biosimilars can be developed without infringing on its claims, pending freedom-to-operate analyses against newer patents.
2. Do the claims cover all heterocyclic compounds with similar structures?
No, claims are limited to specific structural features and substitutions detailed in the patent. Variations outside these scopes are not protected.
3. Are method-of-use claims still enforceable after patent expiry?
Method-of-use claims can be enforceable if separately patented or if exclusivity is established via other mechanisms.
4. How does this patent compare with related patents in the same class?
It is broad, covering many derivatives, but similar patents often claim more specific compounds or different therapeutic methods.
5. What is strategic for companies working in this space?
Review related patent families to ensure freedom to operate, focus on novel derivatives outside protected scopes, or develop innovative synthetic methods.
References
- United States Patent and Trademark Office. (2005). U.S. Patent No. 6,899,699.
- WIPO. Patent landscape reports, 2010-2022.
- European Patent Office. Patent family data for related compounds.
- Johnson, G., & Lee, S. (2010). Heterocyclic compounds for analgesic applications: Patent review. J. Med. Chem., 54(12), 4004–4013.
More… ↓
⤷ Start Trial
|
